Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
about
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@en
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@nl
type
label
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@en
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@nl
prefLabel
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@en
Systemically administered AAV9 ...... ed orthotopic xenograft model.
@nl
P2093
P2860
P356
P1476
Systemically administered AAV9 ...... ved orthotopic xenograft model
@en
P2093
Bakhos A Tannous
Casey A Maguire
Christian E Badr
David P Noske
Rami Kantar
Thomas Würdinger
W Peter Vandertop
P2860
P356
10.1038/MTO.2016.17
P577
2016-06-22T00:00:00Z